Search Results - "Strack, Alison M"
-
1
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes
Published in International journal of biological sciences (01-01-2012)“…Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a promising therapeutic target for treating coronary heart disease. We report a novel antibody 1B20…”
Get full text
Journal Article -
2
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade
Published in American journal of physiology. Regulatory, integrative and comparative physiology (01-07-2000)“…Overexpression of agouti-related peptide (AgRP), an endogenous melanocortin (MC) 3 and 4 receptor antagonist (MC3/4-R), causes obesity. Exogenous…”
Get more information
Journal Article -
3
Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist
Published in Journal of medicinal chemistry (10-10-2002)“…Synthetic and natural peptides that act as nonselective melanocortin receptor agonists have been found to be anorexigenic and to stimulate erectile activity…”
Get full text
Journal Article -
4
Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats
Published in European journal of pharmacology (15-08-2003)“…Central administration of the neuropeptide melanin-concentrating hormone (MCH) stimulates feeding in rodents. We studied the effects of intracerebroventricular…”
Get full text
Journal Article -
5
Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice
Published in The Journal of pharmacology and experimental therapeutics (01-04-2005)“…The metabotropic glutamate receptor subtype mGlu5 modulates central reward pathways. Many transmitter systems within reward pathways affect feeding. We…”
Get more information
Journal Article -
6
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis[S]
Published in Journal of lipid research (01-01-2013)“…The use of nicotinic acid to treat dyslipidemia is limited by induction of a “flushing” response, mediated in part by the interaction of prostaglandin D2…”
Get full text
Journal Article -
7
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity
Published in ACS medicinal chemistry letters (08-03-2012)“…Extensive structure–activity relationship studies of a series derived from atropisomer 1, a previously described chiral benzodiazepine sulfonamide series, led…”
Get full text
Journal Article -
8
Enhanced running wheel activity of both Mch1r- and Pmch-deficient mice
Published in Regulatory peptides (15-01-2005)“…Mch1r-deficient ( Mch1r −/−) mice are hyperphagic, hyperactive, lean, and resistant to diet-induced obesity. To examine whether the MCH1R is involved in…”
Get full text
Journal Article -
9
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9
Published in Cell chemical biology (16-01-2020)“…Proprotein convertase substilisin-like/kexin type 9 (PCSK9) is a serine protease involved in a protein-protein interaction with the low-density lipoprotein…”
Get more information
Journal Article -
10
Modulation of Metabolic Syndrome by Fibroblast Growth Factor 19 (FGF19)?
Published in Endocrinology (Philadelphia) (01-06-2004)Get full text
Journal Article -
11
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Published in European journal of pharmacology (16-08-2002)“…Five G-protein-coupled melanocortin receptors (MC 1–MC 5) are expressed in mammalian tissues. The melanocortin receptors support diverse physiological…”
Get full text
Journal Article -
12
Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia[S]
Published in Journal of lipid research (01-01-2012)“…In an attempt to understand the applicability of various animal models to dyslipidemia in humans and to identify improved preclinical models for target…”
Get full text
Journal Article -
13
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Published in European journal of pharmacology (12-04-2002)“…Five G-protein-coupled melanocortin receptors (MC 1–MC 5) are expressed in mammalian tissues. The melanocortin receptors support diverse physiological…”
Get full text
Journal Article -
14
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
Published in The Journal of experimental medicine (15-08-2005)“…The enzyme 11β–hydroxysteroid dehydrogenase (HSD) type 1 converts inactive cortisone into active cortisol in cells, thereby raising the effective…”
Get full text
Journal Article -
15
Melanocortin-4 Receptor (MC4R) Agonists for the Treatment of Obesity
Published in Journal of medicinal chemistry (13-07-2006)Get full text
Journal Article -
16
Glucocorticoids, chronic stress, and obesity
Published in Progress in brain research (2006)“…Glucocorticoids either inhibit or sensitize stress-induced activity in the hypothalamo-pituitary-adrenal (HPA) axis, depending on time after their…”
Get more information
Journal Article -
17
Regulation of Energy Homeostasis by Bombesin Receptor Subtype-3: Selective Receptor Agonists for the Treatment of Obesity
Published in Cell metabolism (03-02-2010)“…Bombesin receptor subtype 3 (BRS-3) is a G protein coupled receptor whose natural ligand is unknown. We developed potent, selective agonist (Bag-1, Bag-2) and…”
Get full text
Journal Article -
18
Melanin-Concentrating Hormone 1 Receptor-Deficient Mice are Lean, Hyperactive, and Hyperphagic and Have Altered Metabolism
Published in Proceedings of the National Academy of Sciences - PNAS (05-03-2002)“…Melanin-concentrating hormone (MCH) is a cyclic 19-aa hypothalamic neuropeptide derived from a larger prohormone precursor of MCH (Pmch), which also encodes…”
Get full text
Journal Article -
19
Ghrelin Neutralization by a Ribonucleic Acid-SPM Ameliorates Obesity in Diet-Induced Obese Mice
Published in Endocrinology (Philadelphia) (01-03-2006)“…Ghrelin, an acylated peptide secreted from the stomach, acts as a short-term signal of nutrient depletion. Ghrelin is an endogenous ligand for the GH…”
Get full text
Journal Article -
20
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
Published in Nature genetics (01-09-2000)“…Genetic and pharmacological studies have defined a role for the melanocortin-4 receptor (Mc4r) in the regulation of energy homeostasis. The physiological…”
Get full text
Journal Article